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Abstract
Software as a medical device is a relatively new
and expanding field in which patient safety must be a
key concern. Regulation and standards regarding
software as a medical device (subsequently referred to
as “SaMD”) must incorporate all components that
could potentially influence SaMD, both in its
development and implementation. However, SaMD
has been varyingly defined by organisations and
individuals within the literature, therefore there is no
clear boundary as to what is or is not SaMD,
consequently, no clear definition of SaMD exists.
Without a clear definition it therefore becomes
impossible to create standards to regulate SaMD.
Ultimately, this results in increased risks to patient
safety. The purpose of this study was to identify SaMD
concepts through a Scoping Review to establish the
boundaries of SaMD. This has significant impact on
new technology applications to support healthcare
monitoring and healthcare service delivery. This will
ultimately affect how new technology can be regulated
in healthcare and will impact innovation and design in
this field.

1. Introduction
The topic of this scoping review is Software as a
Medical Device (SaMD), which is primarily the use of
computer software applications and mobile
applications for health monitoring and management.
This scoping review begins with an introduction to
SaMD, specifically drawing attention to assessing
current definitions. The challenges in defining the
boundaries for SaMD and correlating these with the
definitions, provides the context for the subsequent
discussion of the literature. Medical apps are an
important component of this context and their role in
SaMD is explored. The scoping review will also
discuss medical device software failures, and critically
analyse potential solutions involving standards.
Following the introduction to SaMD, the review
describes the methods used, the results, the outcome
and the significance of this research.
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1.1. What is SaMD?
The right shift in the population age distribution
has resulted in a demand for more effective health
systems [1]. This challenge can be addressed through
the integration of health information systems and
health technologies. These systems play a beneficial
role in patient safety, can potentially reduce healthcare
costs [2] and are supported by continuing development
in the medical devices field [3]. Similarly, Software
as a Medical Device, otherwise known as SaMD, is a
growth area of health technologies, and is predicted to
continue its expansion within the clinical environment.
Nonetheless, a number of studies have highlighted the
current limitations of SaMD [20]. The main constraint
on the depth of work in this area is the lack of an
universal definition or agreement as to what SaMD
includes or does not include. Many of the main
commentators in this field are concerned with this lack
of consensus and have attempted to create a definition
which can be agreed upon. For example, ISO/IEC
80001 Application of risk management for ITnetworks incorporating medical devices - Part 1:
Roles, responsibilities and activities has defined
medical device software as a “software system that has
been developed for the purpose of being incorporated
into the medical device or that is intended for use as a
medical device in its own right” [3, p.12]. This research
does not use this definition because it specifically
relates to software that is used within a medical device
to function. An alternative definition which has gained
traction, has been suggested recently by the
International Medical Device Regulators Forum
(IMDRF) as “software intended to be used for one or
more medical purposes that perform without being
part of a hardware medical device” [5, p.6].
Interestingly, the Australian Therapeutic Goods
Administration, United States Food and Drug
Administration and Canada Health reference the
IMDRF definition and have not created their own
definition. By comparison, organisations such as the
regulators in the European Union, the Asian
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Harmonization Working Party, the Chinese Food and
Drug Administration, and the Japanese Ministry of
Health, Labour and Welfare, are currently developing
their own SaMD definitions, standards and
regulations. According to the IMDRF definition,
clinical software that assists in the diagnosis,
treatment, prevention or mitigation of a disease is
considered SaMD; however, it is asserted that this
definition does not recognise medical devices that
were previously not intended for medical purposes,
and were unintentionally transformed into a device for
medical purpose. Additionally, the IMDRF definition
is not fit for purpose as it does not provide a clear
definition for software developers and may include
desktop information systems such as those used for
electronic medical records (EMRs). As a result, the
failure to develop an agreed SaMD definition has clear
implications for the boundaries and standards of
SaMD.

2. The Gap in the Literature
A review of the literature has identified gaps in
the development of a definition of SaMD, which
makes it difficult to assess SaMD as an effective tool
in the delivery of healthcare. Currently, there is no
standard definition for SaMD, and no established
boundaries for SaMD. This consequently has direct
impact on the development of standards for SaMD, as
without a concise and agreed definition, affirmed
standards cannot be aligned. This has further
implications for the creation of new technology
applications to support healthcare monitoring, and
healthcare service delivery, in relation to how new
technology can be regulated as well as the impact on
innovation and design. Further, whilst mobile apps are
increasingly popular, it is acknowledged that medical
apps may not form a part of SaMD, and therefore not
be considered regulated devices; even though they
may be used for a medical purpose. This can have
potentially detrimental and even fatal consequences,
as a lack of standardisation of medical apps may result
in no regulation of the software development lifecycle
for such apps; ultimately, this potentially results in
increased risks to patient safety. As a response to this
gap, the following research question were developed.

3. Research Questions
1. Can a definition of SaMD be defined that
articulates the boundaries of SaMD?
2. What are the factors that impact the definition
of SaMD boundaries?

The research questions required analysis of the
SaMD literature and references to identify if
boundaries can be defined, as well as how they can
assist in the creation of an agreed SaMD definition. An
analysis of the literature on medical apps and health
information systems was undertaken to identify the
potential boundaries of SaMD, and how the creation
of standards can be used in the development and use
of SaMD. As a result, established boundaries of SaMD
may result in a framework that could be used to assure
patient safety when using SaMD.

4. Research Method
A scoping review method was chosen to answer
the research questions, as this method provides the
ability to identify key concepts and definitions in the
literature [41]. Subsequently, objectives for the
scoping review were developed from the Research
Questions. These were:
• Research and analyse current literature
on SaMD.
• Research and identify the key elements
of SaMD which are currently missing
from the literature.
• Identify the boundaries of SaMD.
Further sub-questions were developed to assist
with answering both the Objectives and Research
Questions.
• What is SaMD?
• What are the boundaries of SaMD?
• What are medical apps, and how do they
relate to SaMD?
• How is SaMD used?
• Software failure in SaMD
• What are the standards and solutions for
software failure in SaMD?

4.1. Criteria and Identifying Relevant Work
Relevant academic articles meeting the inclusion
criteria were used to create the categories of SaMD.
Appropriate papers were decided on by evaluating
each article to determine its academic quality and
whether the content related to the area of SaMD.
Articles that met the criteria of academic quality
included articles that had been peer reviewed,
published within the last 20 years, and held validity
and reliability. It is important to note that papers older
than 20 years were included as pre-literature, and were
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identified as foundational papers significant to the
research.
Subsequently, a collection of published works
were used to determine what components are
mentioned and used in SaMD. The final step of the
scoping review encompassed the identification of the
categories to inform the boundaries of SaMD.
A search term strategy, which involved searching
the literature based on relevant key terms, was
conducted [42]. The key search terms were derived
from concept mapping the keywords and synonyms of
SaMD. The following key search terms were used:
•
•
•
•
•
•
•
•
•

SaMD
Software as a Medical Device
Medical Device Software
Software as a Medical Device and
information flow
Software as a Medical Device
consequences
Software as a Medical Device and risks
Software as a Medical Device standards
Medical apps
Software as a Medical Device Security.

4.2. Assessing Study Quality
Literature articles in suitable databases that met
the initial search criteria, that were content relevant
and identified as research with rigour were identified.
Eleven databases were searched including Proquest,
Academic One File, and IEEE. The majority of the
literature returned were journal articles; nonetheless
online books, standards and published research papers
were also examined.
To ensure academic rigour, only articles that had
been peer reviewed, and had met the content criteria
were selected, and duplicate articles were eliminated.
The search of the literature resulted in 145 journal
articles, 124 of which were assessed as meeting the
criteria for this scoping review.

4.3. Summarising the Evidence
The 124 literature articles selected were critically
analysed and the information from these articles was
aggregated. The outcome of aggregation resulted in
literature categorisations based on the research subquestions. Table 1 provides the number of articles
identified from the research terms.

Remarkably, no relevant search results were
found using key search terms “SaMD” or “medical
device software”. Of the 124 articles selected, 43
results originated from Proquest, 9 originated from
Academic One file, 18 originated from IEEE, 7
originated from Springer Link, 5 originated from
Google Scholar, 4 originated from Science Direct, 5
originated from Wiley Online, 4 originated from BMJ,
2 originated from JAMA, 10 originated from PMC, 3
originated from Taylor & Francis and 14 originated
from other sources.
Table 1. Articles found from the Research Terms
Research Terms

Total Articles

SaMD

0

Software as a Medical Device

37

Software as a Medical Device
Consequences

1

Software as a Medical Device
information flow

6

Software as a Medical Device
and risks

3

Software as a Medical Device
and Standards

10

Medical apps
Software as a Medical Device
Security

Total

34
33

124

5. Results
The findings from the scoping review indicate
that there is a lack of academic research in the
literature using the acronym “SaMD”. It can be
argued, SaMD is a relatively new field, which may
explain the lack of literature to be found from this
specific acronym term. Further, the articles analysed
were found to have three primary themes: Software,
Standards and Regulation, and Risk Management. The
next section describes the themes, and sub-themes
identified in the literature.

5.1. Software
The theme Software incorporates sub-themes on
functionality, safety and security, and lifecycle
software development. Software, was identified as the
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primary theme in 83 of 124 articles. The secondary
theme of Standards and Regulations was found in 36
of these 83 articles, while Risk Management
accounted for 33 of the 83 articles as a secondary
theme.

5.1.1. Functionality
The category Functionality incorporates the
purpose of the SaMD, the features, the implementation
and clinical use, as well as the various types that are
currently available or in development. Once a device
has been created with the intention of being SaMD, the
safety and security of the device is only considered
post-design. Importantly, these articles highlight the
role of software assurance, safety, security, validation,
and verification in SaMD. Additionally, this theme
considered the role of SaMD functionality and purpose
through the use and workflow of SaMD.

5.1.2. Safety and Security
The safety and security of the SaMD includes the
privacy of data, and vulnerabilities impacting
confidentiality, availability and integrity of the data,
including software vulnerabilities. Safety of the user
using the device is also considered as a factor within
this category.
5.1.3. Software Development Lifecycle
Once standards and regulations incorporate
SaMD into the software development lifecycle,
manufacturers can ensure that the design and
manufacturing of these device are compliant with
standards.

5.2. Standards and Regulations
Once vulnerabilities and threats have been
recognised, standards and regulations can be redeveloped to include methods of addressing software
vulnerabilities within the software development
lifecycle. While standards and regulations were
emphasized as a key theme in 30 of 124 of the articles,
the articles relating to standards and regulation
promoted frameworks that could regulate SaMD and
discussed development of standards relating to SaMD.

5.3. Risk Management
Risk management can be used within the software
development lifecycle to assess risks related to
functionality, and to further assess risks related to the
software deployment lifecycle itself. Risk
management was discussed in 11 of the 124 articles,
which emphasized the importance of regulations with
regards to risk management.
Interestingly, 7 of the 11 risk management articles
also discussed standards and regulations, and 9 of the
11 discussed software themes. Additionally, of the 30
articles that discussed standards and regulations, 7 also
discussed risk management, while 21 of the 30,
discussed software as a secondary theme.
Most significantly, the scoping review found that
the three main themes were not mutually exclusive and
that each article contained primary and secondary
themes. Further analysis of the primary and secondary
themes resulted in identification of common subthemes consistent across the SaMD literature. The
sub-themes identified were:
1. Principles, Concepts and Definitions
2. Standards
3. Classifications
4. Standards created by Organisations
5. Standards Implemented by member states
6. Lifecycle
7. Risk Management
8. Hazards
9. Consequences
10. Patient Safety
11. Research
12. Privacy
13. Security
14. Models and Frameworks
15. Validation and Verification of devices
16. Software assurance
17. Implementation and Clinical Use
18. IT and Clinical Personnel
19. Human Factors
20. Integrity
21. Purpose and Functionality
22. SaMD Types
23. Implantable
24. Health Apps
25. Medical devices with software
26. Wearable
27. Standalone
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28. Wireless
29. Design and Development
These sub-themes were aggregated to the major
themes as represented in Figure 1 and contribute to the
understanding of SaMD components [2, 26-87].
Further analysis revealed what is currently missing
from the SaMD components and. Interestingly, what
is omitted from the literature is any comprehensive
discussion of privacy. Hence, further research
regarding the role of medical apps, and the impact on
privacy is needed. The literature provides some
indication of the boundaries of SaMD, and suggests
that components such as privacy, software and IT
system safety standards are highly important.

leading to uncertainty in the marketplace. The
International Electrotechnical Commission (IEC) and
the International Organization for Standardization
(ISO) through Joint WG7 have explored establishing
guidelines, principles, common terms and definitions
through the development of a road map for SaMD.
This has specific relevance to the boundaries of SaMD
as it will result in better categorisation. In addition,
safety risk classification [3] of SaMD can result in
greater product safety [2]. More importantly, one of the
most critical shortcomings of the current SaMD
definitions and standards are the lack of distinction
between SaMD and medical apps. The next section
explores how SaMD is used according to the literature.

6.2. How SaMD is Used
Implementation
& Clinical use
Standards &
Definitions

Design &
Development

SaMD
Figure 1. Components of SaMD taken from the
literature [2, 26-87]

6. Discussion
6.1. SaMD Boundaries
Cobbaert [6] affirmed that identification of the
intended use of SaMD can determine the boundaries
of SaMD, and that a definition of these SaMD
boundaries will result in a more concise definition
which can be used to create standards. As explained by
the literature, SaMD is complex, as there are several
different contexts for SaMD use. The literature has
demonstrated the multifaceted nature of SaMD and
provides further justification to create standards that
are suited for a rapidly evolving environment.
Majchrowski [7] has explored both software and
hardware contained in medical devices and has
highlighted the importance of considering these
aspects in the development of standards. Until now,
the IMDRF has focused on the creation of a
framework for regulating SaMD [8] which resulted in
the creation of category types for devices based on
public health impact. Hence, the IMDRF definition is
a focused ‘regulator’ approach. This approach is not
applicable to new innovative software and depending
on the context, the definition may or may not be broad
enough. Additionally, the IMDRF definition is not
definitive and leads to interpretation, therefore,

The role of SaMD and how it is used within
the clinical environment is disparate, and has yet to be
fully explored. There is currently confusion as to what
SaMD specifically applies and where it should be
applied. Ellis and Watson [9] report that electronic
records should not be classified as medical devices as
they are data collection tools; however, other authors
[10] differ in this view as clinical support software (for
instance health records, patient information and billing
information) have been claimed to assist with the
diagnosis and treatment of patients. Such an
assessment leads to these tools being classified as
SaMD based on the SaMD IMDRF definition.
Highlighted in Figure 2 are the categories and uses of
SaMD. They include categories such as Patient
Centred, Provider Centred and General Clinical
Software [12, 16, 21-85]. Additionally, the literature
provides some indication of what SaMD is, but there
is little information on SaMD components. Other
categories of SaMD use have been identified, which
include; stand-alone medical devices (active medical
devices) [11], software add-ons and computer
controlled devices [3]. There are a variety of uses for
SaMD technologies, some of which include remote
surgery, intelligent operating rooms [11] real time
sensing, gait diagnosis [12], patient management
software [13], as well as pacemakers, defibrillators and
infusion pumps [14]. In particular, infusion pumps
have been widely used for therapy and diagnosis of
patients [15]. Other uses for SaMD include sensor
management, disease prediction, microelectronic
components and data and device integration [12].
While the literature has classified SaMD into three
distinct categories, little research has been conducted
into what role computer software, smart devices,
medical apps [16, -17] and websites play in SaMD. Few
studies have considered the wearable and implantable
medical devices, wireless devices [14], Bluetooth
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devices [12] and open versus proprietary clinical
software [18] as SaMD. Therefore, further research
into their role in patient safety and the benefits of
SaMD is required.

Figure 2. Categories to which the term SaMD has
been applied [12, 16, 21-87]
The benefits of SaMD are well-recognised with a
reported increase in expenditure (in 2015) and
published worth of $315 billion dollars globally [2].
While, 76% of SaMD deployment in 2015 was located
in the USA, Japan, Italy and France, the USA has the
largest market share with $110 billion dollars spent in
2015, accounting for 35% of the global SaMD market
[2]. Although SaMD represents significant benefits to
patient safety, there is also a perceived and real risk
when these technologies are compromised.
Interestingly, only three of the 124 articles
discussed the need for regulation of medical apps.
However, these articles discussed SaMD regulation,
and suggested frameworks, based on inappropriate and
broad definitions. Further, these articles do not discuss
the boundaries of SaMD, nor do they attempt to define
the boundaries. In addition, the fact that only three
articles of 124 were found to include SaMD regulatory
frameworks suggests that research is still needed on
this topic. The analysis of themes also revealed the
areas of SaMD that require additional research. For
example, there was little published on information
flow and SaMD . Although six of the 124 articles were
found using the search term ‘Software as Medical
Device and information flow’, it was found that these
articles did not discuss how information flow is a
factor in SaMD; therefore, further research into

information flow and SaMD is needed in order to
understand all the aspects of SaMD.
Current risk management standards that look at
software development, medical device manufacture
and safety of health software, all rely upon traditional
risk management as an essential part of the
development process. This can be problematic as
traditional risk management may not encompass
modern SaMD. The optimum solution to this problem
is the development of SaMD standards; this is
however, not a simple and sequential process. Indeed,
the complex and messy formulation of SaMD means
that this is not a straightforward task when the
boundaries of SaMD are not well defined. It was also
found that the SaMD components are not sequentially
linked and therefore a linear framework cannot
provide a suitable solution. A suggested solution is for
a framework that helps all stakeholders’ (developers,
clinicians, and patients) understanding of how SaMD
can be practical, safe and useful, and one which
describes the boundaries, components and
relationships between components.

7. Outcome of the Scoping Review
The primary themes of SaMD from the literature
(refer to Section 5) were further broken down into the
components of SaMD. This analysis resulted in
identification of SaMD categories of use
SaMD categories of use can be classified as:
wireless applications, computer applications and
medical applications. The identification of SaMD
boundaries allows for the initial definition of SaMD
itself.
One specific outcome of the study was that a
revised definition of SaMD was needed and was
developed, as current definitions did not suitably
reflect the boundaries of SaMD. The revised definition
was developed by identifying the purpose of SaMD
and what its role as a device should ideally be. The
main purpose of SaMD is medical management, with
patient focus as the priority. Medical management
refers to the treatment, monitoring, prevention and
diagnosis of the patient. Following the identification
of SaMD’s role, the device architecture was then
identified from the mapping of the boundaries. SaMD
includes computer programs and other software such
as mobile and wireless applications, which was
included within the following initial definition.

7.1. Revised Definition
or

SaMD is standalone computer software programs
mobile applications that assist (treatment,
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monitoring,
prevention,
diagnose)
medical
management of a patient e.g. Medical apps, clinical
information systems.

8. Conclusion
A scoping review of the literature was conducted
to identify the components and boundaries of SaMD.
The purpose of this was to identify if a definition of
SaMD could be described that articulated the
boundaries of SaMD. The consensus view of the
literature revealed that Risk Management, Standards
and Regulations, and Software were all primary and
secondary themes in the literature. As a primary
theme, software was identified as including the subthemes of software development lifecycle, safety and
security of data, as well as functionality. The scoping
review also revealed that SaMD has many categories
of use, which include clinical support software,
diagnosis tools, treatment and assessment tools,
standalone medical devices, software-add-ons,
computer-controlled devices, desktop systems,
wearable and wireless technologies and much more.
Additionally, the overall components of SaMD can be
classified into principles, concepts and definitions,
design and development as well as implementation
and clinical use.
This research has concluded that there is no
consensus view of what SaMD is, as the literature
includes a broad scope that includes computer
applications, wireless devices and medical apps. For
example, the IMDRF define SaMD as “software
intended to be used for one or more medical purposes
that perform without being part of a hardware medical
device” [5, p.6], while the European Commission’s
Medical Devices Coordination Group has reclassified
SaMD under their Medical Device Regulation (MDR).
Additionally, many of the definitions of SaMD are
contextually defined rather than properties based.
Therefore, SaMD has no consistently defined
boundaries as is highly contextual, and therefore could
be considered an impractical term. This leads to
uncertainty in the marketplace and carries an
implication of the need for regulation to avoid the
term. Future research needs to identify the properties
of SaMD in order to define boundaries that can result
in a definition that focuses on assuring patient safety
when developing SaMD applications and using
SaMD. The IMDRF definition of SaMD includes both
high risk and low risk applications. Rather than use a
context term such as SaMD, regulations should state
what software is regulated; through use of clinical
categories, such as EMR, patient registries, health
records, etc. Currently, the term SaMD does not align
with these clinical categories and results in ambiguity

in the marketplace, resulting in difficulty in
interpretation for vendors of the regulations as they do
not know if their software falls within the boundaries
of SaMD. Regulators could look to use the IEC/ISO
82304-1 Standard [19] as a standards-based definition
for SaMD, as this would allow both software
developers and regulators to focus on enhanced
clinical software safety. Further, international
standards implementation may result in greater
oversight for manufacturers of these devices with the
potential to prevent patient harm as well as enhance
privacy and security when using these devices.

9. Significance
This research has specifically drawn attention to
the current lack of a consistent and consensus-based
definition of SaMD. The challenges in defining the
boundaries for SaMD and correlating these with the
definitions have been highlighted and emphasises the
need for this research. In addition, medical apps are an
integral component of this context and their role in
SaMD and medical device software failures needs to
be addressed in order to suggest potential solutions
through standards. Such standards can then be used to
create frameworks to assure patient safety when using
SaMD. This research will impact society by informing
international standards development in this area as
well as potentially the manufacturing practices of
SaMD developers, to minimise information flow and
interoperability issues that have the potential to lead to
medical errors. Consequently, this will contribute to
improved patient safety.

10. Ethical Considerations
No human ethical considerations were required as
data collection was in the form of secondary research;
therefore, the data collected was already published and
does not pose any risks towards animals or people.
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